SCHEMBL21806791

SCHEMBL21806791

CS(=O)(=O)O[C@@H]1CCCC[C@@H]1OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.51
PSEN1 P49768 4/20 0.48
PSEN2 P49810 4/20 0.48
APH1B Q8WW43 4/20 0.48
NCSTN Q92542 4/20 0.48
APH1A Q96BI3 4/20 0.48
PSENEN Q9NZ42 4/20 0.48
HPGD P15428 2/20 0.42
AR P10275 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CTSV O60911 1/20 0.40
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
CTSC P53634 1/20 0.40
CTSF Q9UBX1 1/20 0.40
TACR1 P25103 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21806790 1.00 KCNA5 (0.51) KCNA5PSEN1PSEN2APH1BNCSTN
SCHEMBL21806792 1.00 KCNA5 (0.51) KCNA5PSEN1PSEN2APH1BNCSTN
SCHEMBL22527528 0.94 AR (0.44) KCNA5PSEN1PSEN2APH1BNCSTN
SCHEMBL22527530 0.94 AR (0.44) KCNA5PSEN1PSEN2APH1BNCSTN
SCHEMBL22527529 0.94 AR (0.44) KCNA5PSEN1PSEN2APH1BNCSTN
SCHEMBL21359781 0.83 PSEN1 (0.53) KCNA5PSEN1PSEN2APH1BNCSTN
SCHEMBL16194688 0.81 KCNA5 (0.43) KCNA5PSEN1PSEN2APH1BNCSTN
SCHEMBL16194687 0.81 KCNA5 (0.43) KCNA5PSEN1PSEN2APH1BNCSTN
SCHEMBL24898571 0.81 PSEN1 (0.41) KCNA5PSEN1PSEN2APH1BNCSTN
SCHEMBL22664652 0.81 PSEN1 (0.41) KCNA5PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3853230-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2021-07-28 EP disclosed
WO-2020061279-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2020-03-26 WO disclosed